In colon enterocytes and in well-differentiated colon cancer CaCo-2 cells, InsP 6 (inositol hexakisphosphate) inhibits iron uptake by forming extracellular insoluble iron/InsP 6 complexes. In this study, we confirmed that CaCo-2 cells are not able to take up iron/InsP 6 but, interestingly, found that the cells are able to internalize metal-free and Cr 3 + -bound InsP 6 . Thus, the inability of CaCo-2 cells to take up iron/InsP 6 complexes seems to be due to the iron-bound state of InsP 6. Since recently we demonstrated that the highly malignant bronchial carcinoma H1299 cells internalize and process InsP 6, we examined whether these cells may be able to take up iron/InsP 6 complexes. Indeed, we found that InsP 6 dose-dependently increased uptake of iron and demonstrated that in the iron-bound state InsP 6 is more effectively internalized than in the metal-free or Cr 3 + -bound state, indicating that H1299 cells preferentially take up iron/InsP 6 complexes. Electron microscope and cell fraction assays indicate that after uptake H1299 cells mainly stored InsP 6 /iron in lysosomes as large aggregates, of which about 10 % have been released to the cytosol. However, this InsP 6 -mediated iron transport had no significant effects on cell viability. This result together with our finding that the well-differentiated CaCo-2 cells did not, but the malignant H1299 cells preferentially took up iron/InsP 6, may offer the possibility to selectively transport cytotoxic substances into tumour cells.
INTRODUCTION
In plant cells, InsP 6 (inositol hexakisphosphate) mainly acts as a phosphate source and as a store of multivalent cations, because it binds Mg 2 + , Ca 2 + , Zn 2 + and Fe 3 + with high affinity [1] . Plant seeds express phytases during germination to get access to phosphate and multivalent cations, and mature plants use secreted phytases of rhizosphere bacteria and fungi to dephosphorylate soil InsP 6 [2, 3] . Also mammalian cells express a phytase, the MINPP1 (multiple-inositol-polyphosphate-phosphatase) , which in lung tumour cells (H1299) is processed in the endoplasmic reticulum and subsequently secreted to the medium and transported into lysosomes [4] . The phytase activity of MINPP1 enables the cells to dephosphorylate extracellular InsP 6 Abbreviations used: DCF, dichlorodihydrofluorescein; EM, electron microscopy; InsP 6 , inositol hexakisphosphate; InsPs, inositol phosphates; MDD, metal detection; MINPP1, multiple-inositol-polyphosphate-phosphatase; ROS, reactive oxygen species. 1 To whom correspondence should be addressed (s.windhorst@uke.uni-hamburg.de; p.nielsen@uke.uni-hamburg.de).
and, as H1299 cells are able to internalize extracellular InsP 6 , MINPP1 dephosphorylates InsP 6 after endocytosis in lysosomes. This MINPP1-mediated dephosphorylation of InsP 6 results in release of inositol, phosphate and multivalent cations, thus providing an additional source of micronutrients [4] .
However, high concentrations of InsP 6 mainly have negative cellular effects because physiological levels of phytases are not sufficient to dephosphorylate InsP 6 concentrations 100 μM resulting in depletion of essential multivalent cations from the medium [5] . In enterocytes, this characteristic of InsP 6 can substantially inhibit uptake of non-haem iron, because formation of Fe 3 + /InsP 6 complexes prevents reduction of Fe 3 + by Dcytb (duodenal cytochrome B) and thus transport of non-haem iron by the divalent metal transporter DMT-1 [6] . In particular plant seeds contain high concentrations of InsP 6 and of Fe 3 + and since after destruction of cells InsP 6 and Fe 3 + are released, formation of non-soluble InsP 6 and Fe 3 + complexes reduce the bioavailability of plant iron [7, 8] . Accordingly, it has been shown that in CaCo-2 cells, which serve as cellular model for iron uptake by enterocytes, extracellular InsP 6 inhibits iron uptake (e.g. [9] ). As similar as plants, H1299 cells use extracellular InsP 6 as additional source for micronutrients, in this study we examined if these cells may be able to internalize and process extracellular iron/InsP 6 complexes.
MATERIALS AND METHODS

Cell culture
The cell line H1299 was cultured in DMEM (Dulbecco's modified Eagle's medium); CaCo-2-cells were grown in MEM (Minimal Essential Medium). Both media were supplemented with 10 % (v/v) (FCS), 4 mM L-glutamine, 100 μg/ml streptomycin, and 100 units/ml penicillin. For characteristics of these cells, see American Type Culture Collection (ATCC).
Extraction of InsPs (inositol phosphates)
InsPs were extracted from H1299 and CaCo-2 cells as described in Windhorst et al. [4] . After extraction, InsPs were analysed by MDD (metal detection) HPLC [10] .
Radioactivity measurements
59 FeCl 3 and 51 CrCl 3 in 1 M hydrochloric acid were purchased from Perkin Elmer Rodgau, Germany. Appropriate activities result in 500-2000 Bq per final probe, containing only tracer amounts of iron or chromium, were diluted with aqueous 'cold' FeCl 3 or CrCl 3 solutions to the desired concentrations and then lyophilized to remove HCl. In experiments, with InsP 6, this agent was pre-incubated with 59 Fe or 51 Cr for 1 h at room temperature (25
• C) before adding to the respective cell culture system. 59 Feor 51 Cr-radioactivity was measured in washed cells as well as in pooled medium and wash fractions using a sensitive large volume whole body counter.
Analysis of iron uptake in Caco-2-and H1299-cells in presence and absence of InsP 6 H1299-and CaCo-2-cells (5×10 5 cells/dish) were grown in 3.5 cm dishes at 37
• C and 5 % (v/v) CO 2 in 1 ml cell culture medium for 20 h. An aliquot of 50 μl of each solution containing 59 FeCl 3 with or without InsP 6 was added to cell culture dishes to give an end concentration of 30 μM 59 FeCl 3 and 30 μM InsP 6 . After cautious mixing, cells were incubated at 37
• C overnight. The media were removed and cells were washed five times with PBS.
Dose-dependent influence of InsP 6 on iron uptake in Caco-2-and H1299-cells
The cell lines were grown as described above. Solutions containing 59 FeCl 3 and different amounts of InsP 6 were prepared, pre-incubated for 1 h and then added as 50 μl aliquots to the cell culture dishes (n = 3) to result a final concentration of 30 μM 59 FeCl 3 and InsP 6 (0 μM/dish); (1 μM/dish); (10 μM/dish); (30 μM/dish); (100 μM/dish). After cautious mixing, the cells were incubated overnight at 37
• C and prepared for 59 Fe-activity measurement as described above.
Cell fractionation using differential centrifugations H1299 cells were treated with 30 μM 59 FeCl 3 /30 μM InsP 6 or with 30 μM 59 FeCl 3 only. After incubation for 20 h, the cells were washed five times with PBS and after trypsinization, the cells were centrifuged (7 min 1.200 rev/min room temperature). The pellet was resuspended in 1 ml fractionation buffer (10 mM Tris-HCl pH 7.5, 250 mM sucrose) and the cells were homogenized in a Potter-Elvehejm homogenizer (40 times). Trypanblue staining of homogenized cells revealed that only 20 % of the cells were lysed. However, to avoid destruction of microsomes, the cells were not further homogenized. The homogenized cells were differentially centrifuged as described in [4] . 59 FeCl 3 -radioactivity of P3 as well as of supernatants were measured using the HAMCO-whole body counter. The gamma radiation of the samples was measured for 10×10 s and the mean value of the activity in Bq (Becquerel) was calculated.
Determination of iron-induced formation of ROS (reactive oxygen species)
After cellular uptake of 5,6-chloromethyl-2 ,7 -dichlorodihydrofluorescein diacetate (CM-DCF-DA, Wako) esterases remove the diacetate group leading to formation of DCF (dichlorodihydrofluorescein). After oxidation by ROS DCF is fluorescent with excitation at 490 nm. Thus, the DCF fluorescence is linear to the concentration of cellular ROS. To measure the effect of extracellular FeCl 3 and FeCl 3 /InsP 6 on formation of ROS, 1×10 4 H1299 cells per well were seeded into black 96-well plates. After incubation for 20 h the medium was discharged, the cells were washed twice with PBS and new medium containing 10 μM DCF or, as control, medium without DCF was added to cells and incubation was continued for 1 h. Thereafter, the medium was discharged again, the cells were washed twice with PBS and new medium containing 30 μM FeCl 3 , 30 μM FeCl 3 /30 μM InsP 6 or 30 μM FeCl 3 /100 μM InsP 6 was added and the cells were further incubated for 2 or 20 h, respectively. After these incubation times, the medium was discharged, the cells were washed twice with PBS and 120 μl PBS was added to cells. DCF fluorescence of the cells was measured in a Tecan-Reader at excitation 490 nm; emission 535 nm. The values obtained from cells that were not incubated with DCF (background) were subtracted from the values obtained from cells which were incubated with DCF. Following osmication, the cells were dehydrated using ascending ethyl alcohol concentration steps, followed by two rinses in propylene oxide. Infiltration of the embedding medium was performed by immersing the coverslips in a 1:1 mixture of propylene oxide and Epon and finally in neat Epon and hardened at 60
• C. Ultrathin sections (60 nm) were examined in a EM902 (Zeiss). Pictures were taken with a MegaViewIII digital camera (A. Tröndle,).
RESULTS
InsP 6 alters iron uptake by tumour cells
In order to examine potential differences in iron uptake between H1299 and CaCo-2 cells in presence and absence of InsP 6 , both cell lines were incubated with 30 μM 59 FeCl 3 only as well as with 30 μM 59 FeCl 3 , and different concentrations of InsP 6 (1, 10, 30 and 100 μM) for 20 h. Prior to measurement, the cells were washed five times to redissolve precipitated iron/InsP 6 complexes from the cell surface (see, e.g. [4] ). Cellular iron uptake was examined by analysing the 59 FeCl 3 radioactivity of washed cells. First, we compared uptake of 59 FeCl 3 in absence of InsP 6 between CaCo-2 and H1299 cells and found no significant differences between the cell lines (results not shown). To analyse the effect of InsP 6 on iron uptake, 59 FeCl 3 -signals of control cells (treated with 59 FeCl 3 only), were set to 100 % ( Figure 1A ). As expected, we found that InsP 6 inhibited iron uptake in a dosedependent manner in CaCo-2 cells, by 25 % at low ( of cells incubated with 59 FeCl 3 were set to 100 %. As shown in Figure 1 (B) vitamin C treatment increased iron uptake in both cell lines (by 40 to 50 %), which is in line with numerous reports describing that vitamin C facilitates uptake of iron [8] . Incubation with 30 μM InsP 6 / 59 FeCl 3 again decreased uptake of iron in CaCo-2 and increased its uptake in H1299 cells. In both cell lines, addition of vitamin C to 59 FeCl 3 /InsP 6 complexes reduced the effect of InsP 6 on iron uptake; in H1299 cells 1.5-and in CaCo-2 cells 2.5-fold. This finding supports our assumption that InsP 6 binds Fe 3 + with higher affinity than Fe 2 + . Taken together our data demonstrate that InsP 6 dose dependently increases uptake of iron by highly malignant H1299 lung tumour cells and decreases iron uptake by well-differentiated CaCo-2 colon carcinoma cells, whereby in both cell lines vitamin C reduces the effect of InsP 6 on iron uptake.
H1299 cells preferentially internalize iron-bound InsP 6
Our data that in CaCo-2 cells InsP 6 inhibits iron uptake indicate that these cells are not able to take up InsP 6. To examine this assumption, H1299 and CaCo-2 cells were incubated with either InsP 6 alone or with 30 μM InsP 6 /30 μM FeCl 3 for 24 h and uptake of InsP 6 into cells was analysed by MDD-HPLC. This analysis revealed that in absence of iron both cell lines were able to take up InsP 6 without showing significant differences of the incorporated amount (Figures 2A and 2B ). Whereas addition of FeCl 3 had no significant effect on InsP 6 uptake by CaCo-2 cells, it increased internalization of InsP 6 by H1299 cells by 79 %. After uptake of FeCl 3 /InsP 6 by H1299 cells the concentration of Ins(1,2,4,5,6)P 5 was similar as in cells treated with InsP 6 , although the cells took up higher amounts of InsP 6. This observation might be explained by inhibition of InsP 6 dephosphorylation or it may be that dephosphorylation of InsP 6 is rate limiting as only a fraction of InsP 6 is hydrolysed even in absence of iron.
In conclusion, our data clearly demonstrate that CaCo-2 cells are able to take up iron-free InsP 6 but obviously no iron-bound InsP 6. To analyse if CaCo-2 cells in principle are not able to take up InsP 6 6 were fractioned in endo/lysosomal (P3) and cytosolic fractions. The fractions were evaluated by Western-blotting using antibodies against the specific marker proteins [4] . In Figure 4 (A), the 59 Fe 3 + radioactivity (Bq) of the endo/lysosomal (P3) fraction and of the supernatant (S/N) of cells incubated with 59 FeCl 3 and with 59 FeCl 3 /InsP 6 is depicted. In Figure 4( To further verify this finding, we analysed uptake of FeCl 3 /InsP 6 by EM (electron microscopy). The relatively high electron density of iron compared with other cellular structures is visible by EM as dark amorphous structure [11, 12] . H1299 cells were incubated with 30 μM FeCl 3 /30 μM InsP 6 and in addition, three control approaches were analysed: (1) Figure 4C ). Since these structures were not visible in control cells and resemble those published by Ahlinder et al. [12] , we strongly assume that they represent iron/InsP 6 complexes. In summary, our data indicate that H1299 cells internalize iron/InsP 6 complexes and accumulate them as large aggregates in lysosomes.
Extracellular InsP 6 /FeCl 3 alters expression of ferritin
In order to show if InsP 6 associated iron is completely compartmented after uptake or if iron is also released into the cytoplasm, expression of the iron responsive protein ferritin was analysed. Since ferritin is an iron-storage protein, its expression increases with increasing cytosolic iron concentrations [13] (Figure 5 ) .
This analysis shows that in both, CaCo-2 and H1299 cells, the level of ferritin increased 19-and 24-fold, respectively, after incubating cells with iron alone in comparison with non-treated cells, confirming our observation that H1299 cells can take up iron also in absence of InsP 6 (results not shown). In presence of 100 μM InsP 6 , the ferritin level was reduced 1.3-fold in CaCo-2 cells, which is in line with our data showing that in these cells high InsP 6 concentrations inhibit iron uptake. In H1299 cells, the ferritin level was also lower (2-fold) in cells incubated with iron and 100 μM InsP 6 as compared with cells treated with iron only, although our data show that under these conditions the cells took up about 8-fold more iron than in absence of InsP 6 . From this data, we conclude that in presence of InsP 6 H1299 cells store the main fraction of iron in lysosomes and transport only a small amount (about 10 %) into the cytoplasm.
InsP 6 protects H1299 cells from iron-induced formation of ROS but does not alter cell viability
It has been shown that in vitro InsP 6 prevents iron-induced formation of ROS [14] . To examine if this is also the case in H1299 cells, formation of ROS was examined in iron-and iron/InsP 6 -treated cells. The cells were treated with 30 μM FeCl 3, with 30 μM FeCl 3 /30 μM InsP 6 and with FeCl 3 /100 μM InsP 6 for 2 h ( Figure 6A ) or for 20 h (Figure 6B ), respectively. Measurement of DCF-fluorescence revealed that incubation of H1299 cells with FeCl 3 for 2 h increased formation of ROS 3-fold, while incubation with FeCl 3 /30 μM InsP 6 as well as incubation with FeCl 3 /100 μM InsP 6 had no effect. Thus, InsP 6 seems to prevent iron-induced formation of ROS. However, after long incubation times (20 h), the FeCl 3 -induced formation of ROS was vanished, indicating that during this time ROS were metabolized and free FeCl 3 had been bound to ferritin. Accordingly, also viability of cells incubated with 30 μM FeCl 3, with 30 μM FeCl 3 /30 μM InsP 6 and with FeCl 3 /100 μM InsP 6 was not different from that of control cells ( Figure 6C ).
DISCUSSION
In this study, we demonstrate that InsP 6 strongly promotes iron uptake by the highly malignant lung cancer cell line H1299 but inhibits iron transport by the well-differentiated colon carcinoma cell line CaCo-2. These different behaviours result from the fact that H1299 are able to internalize InsP 6 /Fe 3 + complexes, whereas in CaCo-2 cells the complexes remain extracellular and inhibit uptake of free iron. Interestingly, CaCo-2 cells internalized   . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . iron-free InsP 6 and also InsP 6 /Cr 3 + complexes, showing that in principle the cells are able to take up InsP 6 /metal complexes. Thus, the inability of CaCo-2 cells to internalize InsP 6 /Fe 3 + aggregates must result from the iron-bound state of InsP 6. It is well known that InsP 6 binds iron with high affinity and NMR-studies revealed that one InsP 6 molecule can bind four iron atoms by performing P-O-Fe-O-P bonds, leading to formation of large and stable Fe 3 + -InsP 6 aggregates [15, 16] . Furthermore, Bretti et al. [17] support this assumption. However, despite this preferential uptake of InsP 6 /Fe 3 + also InsP 6 /Cr 3 + complexes were taken up more effectively by H1299 than by CaCo-2 cells. Thus, the ability of H1299 cells to take up InsP 6 -metal-complexes is in general higher than the ability of CaCo-2 cells. Future experiments will elucidate the cellular mechanisms underlying this cell-specific uptake of InsP 6 /Fe 3 + complexes. The mechanism of InsP 6 -mediated iron transport in H1299 cells mainly resembles that of transferrin-mediated iron uptake, because similar to the transferrin-transferrin receptor complex, the iron/InsP 6 complexes are endocytosed and processed in lysosomes. The main fraction of internalized iron/InsP 6 exists as precipitate because iron and InsP 6 in equimolar ratios are poorly soluble at pH 5 [7] and metal-InsP 6 -complexes are more insensitive to dephosphorylation by MINPP1 [17] . However, a small fraction of iron must have been dissociated from InsP 6 and subsequently transported from the lysosomes into the cytosol because the cellular ferritin level of cells treated with InsP 6 and Fe 3 + was 10-fold higher than that of non-treated cells. As at low pH InsP 6 shows a higher affinity for H + than for metal atoms, Fe 3 + might have dissociated from InsP 6 with the time of incubation and InsP 6 becomes accessible to MINPP1-mediated dephosphorylation. The Fe 3 + ions, which are released from InsP 6 could be reduced to Fe 2 + and transported by DMT-1 into the cytosol. However, uptake of iron/InsP 6 did not alter cell viability, which is in contrast to the effect of low concentration of metal-free InsP 6 , which slightly increased proliferation of H1299 cells [4] . We assume that these differences are due to the slow and ineffective dephosphorylation of iron/InsP 6 complexes leading to release of only low concentrations of phosphate, iron and inositol. The finding that iron-bound InsP 6 does not promote viability of lung cancer cells together with our result that well-differentiated CaCo-2 cells are not able to take up iron/InsP 6 complex may offer a new application of iron/InsP 6 . Coupling of cytotoxic substances to the MINPP1-sensitive 3-phosphate group of InsP 6 may enable to transport cytostatica into tumour cells and slowly release them from its carrier. Future experiments will figure out which groups of malignant tumour cells are able to internalize and process InsP 6 and might thus enable a specific transport of cytotoxic substances into malignant tumour cells.
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